Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
about
Radiotherapy combination opportunities leveraging immunity for the next oncology practiceThe Concept of Hormesis in Cancer Therapy - Is Less More?Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapyT-cell receptor gene therapy--ready to go viral?Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cellsEffect of intravenous immunoglobulin on the function of Treg cells derived from immunosuppressed mice with Pseudomonas aeruginosa pneumonia.Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs.Chemoimmunotherapy.Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma modelImmunomodulatory effects of cyclophosphamide and implementations for vaccine design.PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors.Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells.Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccinationThe emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune responseChronic chemoimmunotherapy achieves cure of spontaneous murine mammary tumors via persistent blockade of posttherapy counter-regulationDendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 SignalingImmune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastomaIMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer.Whole recombinant yeast vaccine induces antitumor immunity and improves survival in a genetically engineered mouse model of melanoma.Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancerCpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma modelEffective chemoimmunotherapy with anti-TGFβ antibody and cyclophosphamide in a mouse model of breast cancer.Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy.Therapeutic cancer vaccines in combination with conventional therapy.Cancer immunotherapy and nanomedicine.Contribution of the immune system to the chemotherapeutic response.Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effects.Immunotherapy: a useful strategy to help combat multidrug resistance.Chemoimmunotherapy: reengineering tumor immunity.Targeting Tregs in Malignant Brain Cancer: Overcoming IDO.Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer.Exploiting dendritic cells in the development of cancer vaccines.Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.Clinical overview of metronomic chemotherapy in breast cancer.Dendritic cell-based immunotherapy: a basic review and recent advances.Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome.Effect of Modified Vaccinia Ankara-5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical Trial.Low-dose cyclophosphamide induces anti-tumor T-cell responses which associate with survival in metastatic colorectal cancer.
P2860
Q26738443-655FE487-8D5A-403D-8AD7-85A771ACE431Q26800519-8B22C76D-0F00-4150-8FEB-DC432372E10EQ27027093-43C4F5A2-3FBA-4EE2-9B64-A57CD85638F3Q28081611-6EA0589F-BA69-44A3-8114-EFB1EF1CCEB5Q28732041-8868A79D-9A15-4806-8D25-25324CCD3C5EQ33648112-255F396F-32DE-4FA2-85E3-07A04629E946Q33653210-D43BF1A0-11CA-4A85-B919-589800F8B786Q33896713-DD4F90C0-8A2B-4208-B0F9-9B028881E613Q34058792-3C00C1B2-7512-4343-813A-D678FC4B268AQ34173568-A93B1791-BD64-4EDD-B465-B929C7F833C7Q34187201-947E4569-9B6E-467B-92A1-A97CCC6DB5A9Q34644359-1BDA97B5-E3AD-4C76-8F7B-9028BFF4CCC2Q34732294-64B35D89-F361-4DC0-8BEC-177A007D6109Q34759603-607C78BA-E19E-4BEB-940C-69FC48F37325Q35058213-F90D60E3-C0BD-4775-A589-447FC50E2C9BQ35201890-8E33B489-3747-4750-9A4B-F93C628EA543Q35269390-A9CFB0D9-0CE7-46E8-8EF2-180610742D36Q35674805-5B122A9B-F255-4443-952B-2AB26521D3B4Q35747826-DA56C337-6F3C-4D29-9FBB-205A07368DC9Q35886767-61825744-5887-4B5A-B23F-998207AF7915Q36130491-595E99F0-7185-4F36-9DC0-1E77B2138C2DQ36193004-DAA718E5-25F7-4708-BE55-FB9E9B3B7435Q36600960-44A75BF0-DE41-478D-B373-19EE0EEC4EABQ37459043-AACFD979-B102-4C28-A98B-40037D3AAEC9Q37520816-E157B721-C131-4D18-A0D7-726DAA52A748Q37771267-E56E96FF-621A-4273-966C-6EED12CE0EDEQ37785836-FAACFD71-D002-44BA-BFD1-BB8291A38BFAQ37832967-1042FC77-5EF0-4997-B820-30C5D1C98F4CQ37991701-F44D443D-B2CC-4E3B-8580-130FE33F0A2BQ38000768-4830E174-8EDC-472E-95D7-C2F12CB2CD37Q38079749-4397BCCF-5CF4-4E4F-A002-60139A0697C8Q38110540-D407BA83-AFE2-42CF-BC4B-998FBD292B96Q38115968-0BE9AFAA-9DA0-4E89-B200-0F0B8D5672ADQ38148774-DE529176-A515-4E72-89B7-16BE0CA2A426Q38185156-D9973EBB-A25F-4FF6-BFC3-9783A0BA66E0Q38560651-4C481262-7AE6-4F2B-9C8B-42255E63C11EQ38665350-29E754BE-2B11-4385-BC97-271B0A695333Q39474140-D3910384-CC3D-4AAF-B035-6AD78703D182Q40062688-8448F337-A502-4844-85D5-B68FAF2FB8DAQ40074035-0BFF775B-FAAF-4A6E-BE63-3056253EB32D
P2860
Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cyclophosphamide resets dendri ...... regulatory T cell elimination
@ast
Cyclophosphamide resets dendri ...... regulatory T cell elimination
@en
type
label
Cyclophosphamide resets dendri ...... regulatory T cell elimination
@ast
Cyclophosphamide resets dendri ...... regulatory T cell elimination
@en
prefLabel
Cyclophosphamide resets dendri ...... regulatory T cell elimination
@ast
Cyclophosphamide resets dendri ...... regulatory T cell elimination
@en
P2093
P2860
P1476
Cyclophosphamide resets dendri ...... regulatory T cell elimination
@en
P2093
Karl B Bezak
Kiyoshi Yoshimura
Leo Luznik
Maria A Pletneva
Richard D Schulick
Vedran Radojcic
P2860
P2888
P304
P356
10.1007/S00262-009-0734-3
P577
2009-07-10T00:00:00Z